Company: QXO-PB
Filing Date: 2025-04-21
Form Type: 8-K
Source: 0000950142-25-001119
Chunk: 0

Company: QXO, Inc.
Filing Date: 2025-04-21
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01      Entry into a Material Definitive Agreement.  

On
April 16, 2025, QXO, Inc. (the “ Company”) entered into an underwriting agreement (the “ Underwriting Agreement”)
with Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC (collectively, the “ Underwriters”), pursuant to which the
Company agreed to sell 37,735,850 shares of the Company’s common stock, par value $0.00001 per share (“ Common Stock”),
at a public offering price of $13.25 per share (the “ Offering”). In connection with the Offering, the Company granted the
Underwriters an option to purchase up to an additional 5,660,377 shares of Common Stock. The Company expects to receive net proceeds from
the Offering, after deducting underwriting discounts and commissions, of approximately $490.0 million (or approximately
$564.2 million if the Underwriters
exercise in full their option to purchase additional shares).

The Underwriting Agreement includes customary
representations, warranties and covenants by the Company. It also provides that the Company will indemnify the Underwriters against certain
liabilities, including liabilities under the Securities Act of 1933, as amended (the “ Securities Act”).

The sale of Common Stock was made pursuant to
the Company’s registration statement on Form S-3ASR (File No. 333-281084), as supplemented by a preliminary prospectus supplement,
filed with the Securities and Exchange Commission (the “ SEC”) on April 16, 2025, and a final prospectus supplement, dated
April 16, 2025, filed with the SEC on April 18, 2025 pursuant to Rule 424(b) under the Securities Act.

The foregoing description of the Underwriting
Agreement is not complete and is qualified in its entirety by reference to the complete text of the Underwriting Agreement, a copy of
which is attached as Exhibit 1.1 and incorporated herein by reference.